Healthcare provider profile · identity verified

Indira Kedlaya, MD

Internal Medicine · PUEBLO, CO · NPI 1891771382

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	381	188
Losartan Potassium	Losartan Potassium	279	127
Lisinopril	Lisinopril	214	92
Levothyroxine Sodium	Levothyroxine Sodium	199	87
Amlodipine Besylate	Amlodipine Besylate	183	83
Fluticasone Propionate	Fluticasone Propionate	165	97
Hydrochlorothiazide	Hydrochlorothiazide	163	70
Alendronate Sodium	Alendronate Sodium	161	66
Gabapentin	Gabapentin	148	61
Tamsulosin Hcl	Tamsulosin Hcl	142	64
Simvastatin	Simvastatin	124	53
Omeprazole	Omeprazole	120	68
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	113	42
Albuterol Sulfate Hfa	Albuterol Sulfate	111	62
Atenolol	Atenolol	105	39
Pantoprazole Sodium	Pantoprazole Sodium	98	37
Trazodone Hcl	Trazodone Hcl	88	38
Metformin Hcl Er	Metformin Hcl	86	38
Metoprolol Succinate	Metoprolol Succinate	86	43
Famotidine	Famotidine	81	33
Metoprolol Tartrate	Metoprolol Tartrate	71	26
Metformin Hcl	Metformin Hcl	63	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	61	59
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	32
Cephalexin	Cephalexin	56	46
Ibuprofen	Ibuprofen	55	26
Escitalopram Oxalate	Escitalopram Oxalate	52	23
Rosuvastatin Calcium	Rosuvastatin Calcium	51	24
Celecoxib	Celecoxib	48	21
Duloxetine Hcl	Duloxetine Hcl	45	17
Lorazepam	Lorazepam	45	25
Meloxicam	Meloxicam	43	30
Allopurinol	Allopurinol	39	17
Fluoxetine Hcl	Fluoxetine Hcl	38	15
Pradaxa	Dabigatran Etexilate Mesylate	38	22
Prednisone	Prednisone	37	29
Azithromycin	Azithromycin	35	33
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	34	13
Arexvy	Rsvpref3 Antigen/As01e/Pf	33	33
Sertraline Hcl	Sertraline Hcl	32	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	27
Furosemide	Furosemide	31	17
Montelukast Sodium	Montelukast Sodium	31	15
Ozempic	Semaglutide	31	suppressed
Finasteride	Finasteride	30	15
Triamcinolone Acetonide	Triamcinolone Acetonide	30	20
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	29	29
Wixela Inhub	Fluticasone Propion/Salmeterol	29	18
Zolpidem Tartrate	Zolpidem Tartrate	28	13
Tramadol Hcl	Tramadol Hcl	26	suppressed
Estradiol	Estradiol	25	21
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Spironolactone	Spironolactone	23	12
Digoxin	Digoxin	22	suppressed
Glipizide	Glipizide	22	suppressed
Glipizide Er	Glipizide	22	13
Naproxen	Naproxen	22	20
Alvesco	Ciclesonide	21	12
Hydrocortisone	Hydrocortisone	21	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	18
Bupropion Xl	Bupropion Hcl	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Fluocinonide	Fluocinonide	17	13
Potassium Chloride	Potassium Chloride	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Colchicine	Colchicine	16	11
Doxycycline Monohydrate	Doxycycline Monohydrate	16	12
Mirtazapine	Mirtazapine	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Acyclovir	Acyclovir	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Lactulose	Lactulose	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Tadalafil	Tadalafil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error